Retatrutide 10mg
99.4% HPLC PurityResearch-grade Retatrutide 10mg lyophilised powder. 99.4% HPLC purity, COA verified. Triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
£93.99GBP
NewPre-Order
Retatrutide 20mg
SKU: PW-023 • Batch: PW-260301
99.4% HPLC PurityCOA Verified ✓
Research-grade Retatrutide 20mg lyophilised powder. 99.4% HPLC purity, COA verified. Double-strength vial of the triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
Read the full description ↓£174.99GBP
Available: Pre-Order (7-10 days)
✓Free shipping on orders over £150
✓Tracked international post — Standard £20.79 / Express £36.39
✓Dispatched next business day (orders before 12 noon (UK time))
Frequently Bought Together
Key Research Features
- Double-strength 20mg vial, lower cost per mg
- Triple receptor agonist: GLP-1, GIP, and glucagon
- 99.4% HPLC purity (independently verified)
- Full COA with mass spectrometry confirmation
- LAL endotoxin tested (<1.0 EU/mg)
- GMP-certified sourcing
Molecular Details
- Sequence
- LY3437943 (proprietary triple receptor agonist sequence; see COA for full data)
- Molecular Formula
- C₂₄₉H₃₉₆N₆₈O₇₂
- CAS Number
- 2381089-83-2
- Molecular Weight
- ~5766 Da
- Purity
- 99.4%
- Form
- Lyophilised powder
- Appearance
- White/off-white lyophilised powder
Purity independently verified by an accredited third-party laboratory via HPLC & mass spectrometry.
Usage & Storage
- Quantity
- 20mg / vial
- Dosage Notes
- Research protocols explore GLP-1/GIP/Glucagon receptor agonist activity at varying concentrations. Consult published clinical literature for specific study designs.
- Reconstitution
- Reconstitute with 1–2mL bacteriostatic water. Swirl gently; do not shake. Allow to fully dissolve before use.
- Injection Route
- Subcutaneous (research protocols)
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light. After reconstitution, refrigerate at 2–8°C and use within 4 weeks.
- Packaging
- Sterile, tamper-evident research vial
Description
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This 20mg vial contains the same 99.4% HPLC purity material as our 10mg vial, from the same GMP-certified source and batch testing programme, at a lower cost per milligram.
Every batch undergoes independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch, with a full Certificate of Analysis available.
The 20mg format suits research programmes running extended or multi-arm protocols where a single higher-mass vial reduces per-mg cost and vial handling.
Research & Guides
Frequently Asked Questions: Retatrutide 20mg
Yes. The 20mg vial is filled from the same 99.4% HPLC purity Retatrutide raw material and batch testing programme as our 10mg vial — only the fill mass differs.
Add bacteriostatic water slowly to the vial (1–2mL depending on the concentration your protocol requires). Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use.
Lyophilised Retatrutide should be stored at −20°C for long-term stability. Once reconstituted, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Research Use Only: Important Disclaimer
Retatrutide 20mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable laws and regulations.
Reviews
Questions & Answers
No questions yet — be the first to ask about this product.
